Clinical Trial Update: Ramelteon and Citicoline for Delirium [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial evaluating ramelteon and citicoline for delirium has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Citicoline (CDP-choline)
• ROZEREM (ramelteon)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Delirium | Phase 4 | Status: WITHDRAWN